Forus reached $1 billion valuation by dealing with the unglamorous admin work of processing scrips so patients can get the drugs they need.

Nearly one third of Americans never fill the prescriptions that their doctors order. Sahir Jaggi thinks AI can help.

In 2023, he started Forus (then named Tandem) to develop AI software that can handle prescriptions’ administrative backend. The moment a physician writes a scrip, Forus’s system picks it up and processes it, figuring out nitty-gritty details like what medications a patient has tried previously and whether there are restrictions on which pharmacy can fill it. Both the doctor and the patient can see what’s going on in real time. “We reduce a huge amount of headache, paperwork and phone calls,” says Jaggi, 31.

The company says that thousands of medical practices and health systems across the country currently rely on its tech, with a 10-fold annual increase for the past two years, driven almost entirely by word of mouth. Medical practices that use its software have seen an increase in prescription fill rates over time, Jaggi says.

Forus said today that it had reached a $1 billion valuation, with $160 million in total funding. Its investors include Thrive Capital, General Catalyst and Accel, each of which led a previously unannounced round of funding. Forus said that its annualized revenue surpassed $10 million by yearend, and that it has roughly quintupled so far this year. That means annualized........

© Forbes